Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
anti-microbial resistance
CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf (Nafithromycin)
Miqnaf is an ultra-short course, once-a-day, 3-day treatment for community-acquired bacterial pneumonia (CABP) including those…
A new photocatalyst can efficiently degrade broad-spectrum antibiotics
The team of scientists utilised hydrothermal reaction of zinc chloride, copper chloride, tin chloride and tungsten disulfide…
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
Cipla Therapeutics and SIGA Technologies enter into strategic partnership
Cipla Therapeutics, an affiliate of Cipla and SIGA Technologies announced entering into a strategic partnership to deliver…
Cipla acquires anti-infective product Elores from Venus Remedies
The acquisition is aimed at further strengthening the firm's presence in branded Indian critical care space, and as a part of its…